Back to search

Virginia Tech

Elucidation of the Biosynthetic Pathway of the Iridoid Glycoside Monotropein and Its Association with Specialized Metabolism and Flavor in Blueberry

Abstract

dc:description.abstract

Blueberries (Vaccinium spp.) are valued for their health-promoting phytochemicals, including polyphenols and flavonoids, and some cultivars additionally accumulate monotropein, a bioactive iridoid glycoside with anti-inflammatory and neuroprotective properties. However, the genetic basis of monotropein accumulation and its potential relationship with fruit flavor metabolism are poorly understood. This study combined analytical chemistry, comparative genomics, transcriptomics, and metabolomics to investigate monotropein biosynthesis and its metabolic consequences in blueberry. Chapter 1: Optimization of protocol for accurate detection and quantification of monotropein (iridoid glycoside) from blueberry tissues Chapter 2: Identification of the iridoid glycoside monotropein biosynthetic pathway in blueberry using computational and molecular biology Chapter 3: Characterization of the variation in monotropein levels and its association with specialized metabolites in blueberry genotypes Blueberries are an economically important fruit crop rich in bioactive compounds like polyphenols and flavonoids. Blueberries have recently been reported to contain monotropein. However, methods to quantify monotropein levels in blueberries have not been optimized. To address this gap, we have developed and optimized an analytical method for monotropein extraction and quantification using liquid chromatography tandem mass spectrometry (LC-MS/MS). Different extraction strategies were compared, including variations in temperature, time, and ultrasonication treatments. Optimal extraction was achieved by heating samples to 60° C for 15 minutes in methanol. The method had high percent recovery (89-110% intraday; 91-108% interday) and good repeatability (1.17-2.15% relative standard deviation (RSD) intraday; 4.68-7.16% RSD interday). This protocol was then applied to 28 blueberry cultivars, 14 of which had not been previously analyzed for monotropein levels. Monotropein levels ranged from 0-1807 ng/mg (DW), The developed method can be applied to future evaluations of monotropein in diverse blueberry cultivars. To understand why cultivated blueberry produces lower levels of monotropein we performed comparative transcriptomic analysis and biosynthetic gene discovery in a pair of cultivars that produced high and low levels of monotropein. In our study, liquid chromatography-mass spectrometry (LC-MS) analysis identified 'Titan' as a monotropein-positive (M⁺) cultivar and 'Georgia Dawn' as a monotropein-negative (M⁻) cultivar. We then performed comparative orthology analysis to identify monotropein biosynthetic genes in blueberry using four different Vaccinium genotypes (Titan, Georgia Dawn, Draper (M-, V. corymbosum) and V. darrowii (M+, syn. V. ashei)) and the iridoid-producing plant Catharanthus roseus. Using orthology analysis and basic local alignment search tool (BLAST) we identified six of the core pathway genes in all Vaccinium genotypes. To further investigate genotype- and organ-specific regulation, transcriptomic and co-expression analysis was performed and correlated with metabolite data. Gene expression patterns showed no correlation with monotropein accumulation, suggesting that transcriptional regulation alone does not explain the observed metabolic differences. Moreover, gene cluster analysis further conveyed that the none of the genes in a monotropein biosynthetic pathway clustered together. We also identified three candidate oxidase genes that perform the final tailoring step in monotropein biosynthesis. Ongoing work focuses on functional validation of GES from M⁺ and M⁻ genotypes using heterologous expression systems. Enzymatic assays are needed to confirm the role of GES in determining monotropein biosynthesis. Finally, to determine whether increasing monotropein content could alter fruit quality, untargeted metabolomic profiling was conducted using LC-MS and GC-MS to identify different which are changing along with monotropein in different genotypes under study. We hypothesize that enhanced iridoid biosynthesis may also affect other metabolites as well in these genotypes. Monotropein abundance was positively associated with numerous flavonoids and terpenoid flavor compounds. These findings indicate different specialized metabolites including flavor metabolites might change in genotypes with varying amounts of monotropein. These changes can also affect consumer acceptance and marketability.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Horticulture
Department dc:contributor.department
Horticulture
Grantor dc:publisher
Virginia Tech
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kaur, Ishveen
Chair dc:contributor.committeechair
  • Leisner, Courtney Price
Committee members dc:contributor.committeemember
  • Cladis, Dennis
  • Wright, Robert Clay
  • Colla'kova', Eva

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Other
vt_gsexam:47486

Chain of custody

source
Harvested from
Virginia Tech
Base URL
vtechworks.lib.vt.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kaur, Ishveen. Elucidation of the Biosynthetic Pathway of the Iridoid Glycoside Monotropein and Its Association with Specialized Metabolism and Flavor in Blueberry. doctoral thesis, Virginia Tech, 2026. https://hdl.handle.net/10919/143725